JMBI-001

N/A

Report date: 2024/07/04 18:02:49
NME

Base Information

Drug NameJMBI-001
Drug Alias NameJMBI-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF20A inhibitors
TargetsKinesin-like protein KIF20A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJ Michael Bishop Institute of Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesAnticancer Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A